Back to top

IONS Maintained by Leerink Partners -- Price Target Raised to $122

IONS Maintained by Leerink Partners -- Price Target Raised to $122

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Ionis Pharmaceuticals, Inc. (IONS)